Publication | Closed Access

Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes

GlomerulonephritisUrologyMaintenance ImmunosuppressionAutoimmune DiseaseRenal FunctionMedicineKidney FailureRenal PathologyImmunologyLupus NephritisRituximab DoseChronic Kidney DiseaseSteroid-dependent/frequently-relapsing Nephrotic SyndromeNephrology